tiprankstipranks
Trending News
More News >
Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ:PCSA
US Market

Processa Pharmaceuticals (PCSA) Income Statement

Compare
331 Followers

Processa Pharmaceuticals Income Statement

Last quarter (Q3 2025), Processa Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Processa Pharmaceuticals's net income was $-3.44M. See Processa Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ -882.06K
Operating Expenses
$ 12.05M$ 11.46M$ 27.53M$ 12.13M$ 14.25M
Depreciation and Amortization
$ 782.00$ 222.00$ 788.50K$ 790.97K$ 882.06K
EBITDA
$ -12.05M$ -11.46M$ -19.47M$ -10.78M$ -14.25M
Operating Income
$ -12.05M$ -11.46M$ -27.53M$ -12.13M$ -15.14M
Other Income/Expenses
$ 201.09K$ 335.54K$ 101.20K$ 175.40K$ -277.95K
Pretax Income
$ -11.85M$ -11.12M$ -27.42M$ -11.96M$ -15.41M
Net Income
$ -11.85M$ -11.12M$ -27.42M$ -11.43M$ -19.04M
Per Share Metrics
Basic EPS
$ -96.75$ -212.00$ -42.50$ -373.00$ -1.27K
Diluted EPS
$ -96.75$ -212.00$ -42.50$ -373.00$ -1.27K
Weighted Average Shares Outstanding
122.40K 52.46K 32.22K 30.64K 15.00K
Weighted Average Shares Outstanding (Diluted)
122.40K 52.46K 32.22K 30.64K 15.00K
Currency in USD

Processa Pharmaceuticals Earnings and Revenue History